BioSyent Inc. announced the retirement of two long-serving Directors, Mr. Douglas Larson and Mr. Milton Wakefield, from its Board of Directors. BioSyent also announced the appointment of Mr. Larry Andrews and Ms. Sara Elford to its Board of Directors. Mr. Andrews is an accomplished senior executive with more than 37 years of experience in the pharmaceutical industry. Ms. Elford previously served as an Independent Director of Pure Technologies Ltd.